Honestly why I would love it, not really sure whether they are allowed to do it in the terms and conditions of the trial to ensure impartiality. An early conclusion - assuming positive with very high survival rate - would be fantastic for the patients and also for those who are waiting for a "miracle" and of course for the investors. While sitting on pins, I rather wait and get it when it is allowed to be released and a (hopefully) great outcome cannot jeopardise the FDA approval, especially early. I am sure there is plenty of pressure to stop more people dying.
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS, page-169
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |